Oncology Solutions
Four instruments.
All live.
Drug AE.
Side-by-side adverse effect burden analysis for individual drugs or full regimens. System organ class profiles visualised as a radar chart, with actuarially combined incidence modelling for multi-drug regimen comparison.
Open Drug AE →Drug Sync.
Multi-drug interaction analysis across complex combinations. Identifies clinically significant interactions, contraindications, and dose adjustment requirements with reference to established clinical databases.
Open Drug Sync →Drug Label.
Full FDA prescribing information with collapsible section navigation, alongside clinical trial adverse-event incidence drawn from posted ClinicalTrials.gov results. Per-arm, per-drug rates sourced directly from trial data.
Open Drug Label →Drug Calculator.
Per-cycle oncology regimen costing from Medicine Price Registry (MPR) data. Dose-adjusted for BSA, weight, and creatinine clearance. Least-cost vial packing, facility fee classification, and net drug cost estimates.
Open Drug Calculator →Built for every stakeholder in clinical care.
Clinical Teams
Physicians, pharmacists, and clinical specialists accessing drug safety and interaction data at the point of prescribing.
- Adverse effect profiling
- Drug interaction screening
- Burden-ranked safety comparison
Medical Schemes
Benefits coordinators and clinical reviewers evaluating treatment requests against clinical evidence and safety data.
- Drug safety evidence
- Comparative burden scores
- System organ class breakdown
Pharmaceutical Partners
Medical affairs and market access teams assessing clinical positioning and safety profiles for drug portfolios.
- Cross-drug AE comparison
- Published incidence data
- System-level granularity